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Introduction: Rapidly growing mycobacteria are opportunistic pathogens in patients with underlying risk factors.
Mycobacterium abscessus subsp. bolletii is a newly recognized member of rapidly growing mycobacteria, isolated
from respiratory tract and cutaneous infections.
Case presentation: We describe a case of chronic disseminated infection caused by M. abscessus subsp. bolletii in a
38-year-old Sri Lankan man with idiopathic CD4+ T lymphocytopenia. Idiopathic CD4+ T lymphocytopenia is a rare
cause of immunodysfunction that, similar to human immunodeficiency virus infection, causes a depletion of CD4+
T lymphocytes. M. abscessus subsp. bolletii infection was diagnosed by culture isolation from two sputum samples.
Conclusions: To the best of our knowledge this is the first report of M. abscessus subsp. bolletii disseminated
infection in a patient affected by idiopathic CD4+ T lymphocytopenia. In contrast to previous reports, the isolate of
M. abscessus subsp. bolletii presented intermediate resistance to clarithromycin and was susceptible to cefoxitin and
imipenem.
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Rapidly growing mycobacteria (RGM) are opportunistic
pathogens in patients with underlying risk factors. These
organisms are ubiquitous in soil and water and can
cause skin, soft tissue, pulmonary, and central nervous
system (CNS) infections and disseminated disease [1].
Mycobacterium abscessus subsp. bolletii is a newly
recognized member of the RGM family, isolated from
respiratory tract and cutaneous infections [2-7].
Idiopathic CD4+ T lymphocytopenia (ICL) is a
rare syndrome, defined in 1992 as: (1) absolute CD4+
T lymphocyte level <300cells/μL or <20% of total lym-
phocytes at a minimum of two separate time points at* Correspondence: raffaellarubino@libero.it
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reproduction in any medium, provided the orleast six weeks apart; (2) no serological evidence of
human immunodeficiency virus (HIV) infection; (3)
the absence of any defined immunodeficiency or ther-
apy associated with depressed levels of CD4+ T cells
[8,9]. The epidemiologic data do not suggest that the
condition is caused by a transmissible agent and the
exact incidence of the disease is variable according to
different studies. Unlike HIV infection, the decrease in
the CD4+ cell counts of patients with ICL is often slow
or even absent over time, the number of CD8+ T cells
is normal, and the immunoglobulin levels are either
normal or slightly low. The pathogenesis of ICL may be
multi-factorial. The diminished availability of stem cell
precursors, the increased T cell apoptosis, the defective
production of tumor necrosis factor (TNF)α and inter-
feron (IFN)γ, the CD4+T cell antibody production and
impaired early biochemical events of the CD3-Tcell receptoral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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+T cell depletion in patients with ICL. ICL is typically diag-
nosed in middle age, usually after an opportunistic infection
[9]. CD4+T cells have a key role in the immunological re-
sponse against mycobacterial infections and other parasitic
and viral infections. Cryptococcal and nontuberculous
mycobacterial infections are the major presenting opportun-
istic infections [10]. We describe a case of chronic dissemi-
nated infection caused by M. abscessus subsp. bolletii in a
patient with ICL.
Case presentation
Our patient was a 38-year-old previous healthy Sri Lankan
man who had been living in Italy for two years. At ad-
mission only a history of allergic rhinitis was reported
and corticosteroids intake was denied. He was diag-
nosed with a right pleural empyema and tubercular
spondylitis. Ziehl-Neelsen staining of his pleural exud-
ate yielded acid-fast bacilli and a biopsy of the pleura
showed mycobacterial histopathological features.
Our patient was treated with an anti-tubercular treat-
ment of isoniazid (300mg once a day, orally), ethambutol
(400mg three times a day, orally), rifampicin (600mg
once a day, orally) and pyrazinamide (500mg three times
a day, orally) for one year.
After 15 months, our patient developed seizures and
was admitted to an emergency room. Magnetic reson-
ance imaging (MRI) scan of the brain revealed a nodular
lesion in the right frontal lobe surrounded by peri-
lesional edema. A thoracic computed tomography (CT)
scan showed parenchymal consolidation in both lungs,
predominantly in the right side (Figure 1). Acid-fast ba-
cilli were detected on a Ziehl-Neelsen-stained sputum
smear and in his bronchial aspirate. A polymerase chain re-
action (PCR) investigation for Mycobacterium tuberculosis
performed on a bronchial aspirate sample yielded a negative
result. A culture of bronchial aspirate yielded nontubercu-
lous mycobacteria. Our patient was moved to our Infec-
tious Diseases Department at the University Hospital of
Palermo.
On admission, our patient was afebrile. He complained
of having had a cough for several weeks, sputum pro-
duction and weight loss (5kg during the last two
months). On chest auscultation, a reduction of vesicular
breath sound was heard in the right lung base. On skin
examination, painless mobile subcutaneous nodules, re-
cently appeared, were seen on the frontal region, the
scrotum and the left thigh. His abdominal, cardiac and
neurological examination results were normal. He was
on phenobarbital treatment.
Laboratory analyses showed a white blood cell count
of 5.14 × 103cells/μL, a hemoglobin level of 12.7g/dL,
and a platelet count of 235 × 103cells/μL. The total
lymphocyte count was 580cells/μL and the CD4+ Tlymphocyte level was 138cells/μL, corresponding to
23.9% of total lymphocytes. His serum immunoglobulin
level was within normal limits.
The results of an HIV antibody test conducted on ad-
mission were negative, and again negative when the
test was repeated two months later. Intra-dermal
Mantoux testing results and serology tests for
human T-lymphotropic virus (HTLV)1 and HTLV2
were also all negative. IgM and IgG anti-Toxoplasma gon-
dii tests were negative, and cytomegalovirus (CMV) IgG
were present. Our patient refused a lumbar puncture.
Pneumocystis jirovecii was investigated using sputum sam-
ples and the results were negative. Therapy with anti-
tubercular drugs (ethambutol 400mg three times a day, or-
ally, isoniazid 300mg a day, orally and pyrazinamide
500mg three times a day, orally) had been maintained be-
cause of a history of tubercular pleurisy and spondylodisci-
tis. We started clarithromycin (500mg twice a day, orally)
and rifabutin (450mg once a day, orally). Ziehl-Neelsen
staining, culture and PCR tests for M. tuberculosis per-
formed on three different sputum and urine samples all
gave negative results. CD4+ T lymphocyte counts per-
sisted at under 200cells/μL until discharge one month
later.
Ultrasonography of the nodules revealed confined
hyper-echoic areas with small hypo-echoic nodules and
spotty blood flow signals in the subcutaneous cellular
tissue. Testicular ultrasonography revealed diffuse en-
largement and heterogeneous echo texture of the right
epididymis, a small hypo-echoic nodule in an enlarged
right testis, and a minimal hydrocele.
At discharge, the subcutaneous nodules had almost
retreated but a chest radiograph revealed a new paren-
chymal consolidation area in the left lung. Our patient
continued the abovementioned treatment until May
2008, when he arbitrarily stopped hospital follow-up and
therapy.
Two years after diagnosis, our patient came back to
our facility because of a new episode of seizures. Brain
MRI scan findings were unmodified and a chest radio-
graph revealed multiple infiltrates involving both lungs.
His CD4+ T lymphocyte count was 169cells/μL. Ziehl-
Neelsen staining of a sputum specimen was positive for
acid-fast bacilli, while PCR for M. tuberculosis was nega-
tive. While waiting for microbiological culture results,
we started a treatment that could act against nontubercu-
lous mycobacteria (clarithromycin 500mg twice a day, rifa-
butin 300mg once a day and ciprofloxacin 500mg twice a
day). Cultures on both solid (Löwenstein–Jensen) and li-
quid (MGIT™ Becton Dickinson, Sparks, MD USA) media
yielded the presence of acid-fast bacilli. The culture isolate
was identified by analysis of its characteristics on culture
(time for growth, colony morphology, pigment production,
ability of the isolate to grow at various temperatures on 5%
Figure 1 Computed tomography image of lung infection by Mycobacterium abscessus subsp. bolletii. The white arrows show parenchymal
consolidation in both lungs, predominantly in the right side, and patchy ground-glass appearance with nodules.
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quence analysis of its ribonucleic acid (RNA) poly-
merase β-subunit-encoding gene (rpoB) as M.
abscessus subsp. bolletii [4]. In particular, after PCR
amplification by using the consensus primers
described by Adékambi et al. sequences correspond-
ing to 752 bp of the rpoB gene were identified by
similarity analysis with the sequences in the GenBank
database by use of the Basic Local Alignment Search
Tool (BLAST) software (http://www.ncbi.nlm.nih.gov/
BLAST). Anti-microbial drug susceptibility tests were
performed using the methods described by Adékambi
et al. [5]. The results are shown in the Table 1. The
results of the anti-microbial susceptibility tests were
interpreted according with the criteria proposed by
the Clinical and Laboratory Standard Institute (CLSI,
formerly NCCLS) and Brown-Elliot et al. [6,7].
Treatment was switched to azithromycin (500mg once
a day, orally) and minocycline (100mg twice a day, or-
ally). Because of the appearance of inguinal and axillary
lymphadenopathy, a biopsy of inguinal lymph nodes was
performed and this showed necrotizing granulomatous
lymphadenitis. No acid-fast bacilli were seen on Ziehl-
Neelsen staining. Three months after the first positive
culture, M. abscessus subsp. bolletii was again isolated
from sputum samples. Our patient is still on therapy andambulatory follow-up and is in a good clinical condition.
We did not perform an MRI because he refused any
other diagnostic procedure.
Discussion
M. bolletii is a nontuberculous mycobacteria recently re-
classified as a subspecies of M. abscessus and renamed
M. abscessus subsp. bolletii [2]. It has been described in
respiratory tract infections in patients with coexisting
broncho-pulmonary diseases and in subcutaneous infec-
tions from patients who had undergone mesotherapy
[8,9,11].
RGM respiratory disease most often affects patients
older than 60 years. Almost all patients younger than
40 years have one of the predisposing disorders [12,13].
The first case of disseminated M. abscessus subsp.
bolletii infection in a young adult patient was described by
Koh et al. [13]. Our patient was affected by ICL, a rare
cause of immunodysfunction that, similar to HIV infection,
causes a depletion of CD4+ T lymphocytes. ICL diagnosis
was confirmed by persistent CD4+ T lymphocytes count
under 300cells/μL in the absence of HIV infection and
common variable immunodeficiency.
The clinical spectrum of ICL ranges from an asymp-
tomatic laboratory abnormality to life-threatening com-
plications. ICL is typically revealed by the emergence of
Table 1 Anti-microbial drug susceptibility test results for Mycobacterium abscessus subsp. bolletii isolate
Anti-microbial agent Minimum inhibitory concentration (MIC) (μg/mL) Interpretive criteria [7]
Amikacina 32 Intermediate
Amoxicillin clavulanateb >256 Resistant
Cefotaximec (disk, 30μg) >64 Resistant
Cefoxitinb <8 Susceptible
Ciprofloxacina >16 Resistant
Clarithromycina 16 Resistant
Cotrimoxazolec (disk, 1.25/23.75μg) >8 Resistant
Erythromycinc (disk, 15μg) >8 Resistant
Imipenemb 0.75 Susceptible
Levofloxacinc (disk, 5μg) >4 Resistant
Linezolidc (disk, 30μg) >8 Intermediate/Resistant
Minocyclinec (disk, 30μg) <4 Susceptible
Ofloxacinc (disk, 5μg) >8 Resistant
Teicoplaninb >256 Resistant
Tobramycinc (disk, 10μg) >8 Resistant
Tigecyclineb >256 Resistant
Vancomycinb >256 Resistant
aBroth microdilution; bEtestW (AB Biodisk) at 30°C for 72 hours incubation; cdisk diffusion.
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bacteria and Cryptococcus spp. [14,15]. Disseminated
mycobacterial infections have been rarely reported in
patients affected by ICL [16-18]. This is the first report
of M. abscessus subsp. bolletii infection in a patient
affected by ICL. Our patient presented with a multi-
focal spread of M. abscessus subsp. bolletii infection
consisting in pulmonary, CNS, genital, lymphonodal,
subcutaneous involvement. Pulmonary disease is an un-
common but clinically relevant entity caused by RGM,
most often by the M. abscessus group [19].
CNS is a rare localization of RGM infection. The most
common cause is dissemination from pulmonary infec-
tion [1]. The clinical presentation was dominated by the
sudden appearance of seizures due to a frontal lobe
nodular lesion. A cerebral localization of M. abscessus
subsp. bolletii is highly probable due to the concomitant
presence of chronic lung infection in a patient who is
immunocompromised and the presented MRI findings.
Orchiepididymitis, lymphadenitis and subcutaneous
nodules could be interpreted as other localizations pre-
sumably due to hematogenous spread from M. abscessus
subsp. bolletii lung infection. Ultrasonographic and/or
microscopic pictures were suggestive for mycobacterial
infection [12,20,21].
As other RGM, M. abscessus subsp. bolletii is char-
acterized by an inherent resistance to first-line anti-
tuberculous drugs. In addition, it has been described
as a multi-drug resistant mycobacterium, notably to
clarithromycin but with intermediate resistance toamikacin [4]. In contrast, in our patient’s case the iso-
late of M. abscessus subsp. bolletii presented resistance
to clarithromycin and was susceptible to cefoxitin, imi-
penem and minocycline (Table 1). It has been reported
by Wallace et al. that the activity of tigecycline in vitro
against several species of RGM was 11 times higher
than other tetracyclines [21]. Conversely, the present
M. abscessus subsp. bolletii isolate was resistant to tige-
cycline despite its susceptibility to minocycline. These
differences could be due either to variability in anti-
biotic susceptibility within M. abscessus species or to
the employ of different laboratory methods [22]. The
therapeutic choice of azithromycin and minocycline
was determined by our patient’s poor compliance and
by its ability to cross the hematoencephalic barrier.
The natural course of our patient’s infection seems to
be indolent even if the few descriptions of M. abscessus
subsp. bolletii respiratory infection show high lethality
[9]. However, the appropriateness of the therapeutic regi-
men could have also been negatively affected by some in-
consistencies of the susceptibility testing approach.
The actual prognosis is difficult to establish because of
his concomitant ICL, which continuously predisposes
patients to various opportunistic infections.
Conclusions
Accurate identification of RGM species is very important
with regard to their different drug susceptibility patterns,
clinical significance and prognosis [19]. The emergence
of new multi-drug resistant species is a threat in
Colomba et al. Journal of Medical Case Reports 2012, 6:277 Page 5 of 5
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immune system impairment of different origin.
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